SBFM — Sunshine Biopharma Share News
0.000.00%
- $2.28m
- -$11.45m
- $36.31m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:33 AM
Brief: Sunshine Biopharma Says Health Canada Approves Atenolol For Treating Cardiovascular Conditions
Brief: Sunshine Biopharma Receives Canadian Regulatory Approval For Enalapril
Brief: Sunshine Biopharma - Enters At-The-Market Sales Agreement With Aegis Capital For Up To $4 Million - SEC Filing
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
NASDAQ RESUMED AT 12:51 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:51 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:49 PM
NASDAQ RESUMED AT 12:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:29 PM
NASDAQ RESUMED AT 12:29 PM
NASDAQ RESUMED AT 12:19 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:19 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:17 PM
NASDAQ RESUMED AT 12:03 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:00 PM